| Name | nicotinamide phosphoribosyltransferase |
| Description | This gene encodes a protein that catalyzes the condensation of nicotinamide with 5-phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, one step in the biosynthesis of nicotinamide adenine dinucleotide. The protein belongs to the nicotinic acid phosphoribosyltransferase (NAPRTase) family and is thought to be involved in many important biological processes, including metabolism, stress response and aging. This gene has a pseudogene on chromosome 10. [provided by RefSeq, Feb 2011] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nNAMPT is best known for its critical intracellular role as the rate‐limiting enzyme in the NAD⁺ salvage pathway, a function pivotal for maintaining cellular energy and redox homeostasis. By catalyzing the conversion of nicotinamide to nicotinamide mononucleotide (NMN), NAMPT supports NAD⁺ production required for the activity of NAD⁺‐dependent enzymes such as sirtuins, which are important for metabolism, mitochondrial integrity, stress resistance, and longevity. Fasting‐induced increases in NAMPT expression help preserve mitochondrial NAD⁺ levels and protect cells from genotoxic stress, while extracellular vesicle–mediated delivery of NAMPT contributes to systemic NAD⁺ biosynthesis and anti‐aging effects."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "6"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its intracellular enzymatic activity, NAMPT is also found in the extracellular milieu under the names visfatin or pre‐B cell colony–enhancing factor (PBEF). As an adipokine and proinflammatory cytokine, extracellular NAMPT influences immune cell function and inflammatory responses, stimulates cytokine production, and modulates insulin signaling. These actions appear to contribute to the pathophysiology of obesity, insulin resistance, and various inflammatory diseases."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "7", "end_ref": "13"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nNAMPT’s contributions extend to the regulation of cell survival, proliferation, and stress responses in pathological states such as cancer. Upregulation of NAMPT has been linked to enhanced tumor cell growth, improved resistance to oxidative stress, and the promotion of cancer stem cell–like properties—all of which may occur via NAD⁺–dependent modulation of factors like SIRT1 and p53. These findings underscore its potential as both a prognostic marker and a therapeutic target across a range of malignancies."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "14", "end_ref": "21"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its roles in metabolism and cancer, NAMPT also modulates immune cell function and contributes to vascular, inflammatory, and stress‐related responses. Inhibition of NAMPT has been shown to deplete NAD⁺, impairing T lymphocyte activation and cytokine secretion, which highlights its relevance in immune–mediated disorders. In cardiovascular cells and in lung injury models, aberrant NAMPT expression is linked to altered inflammatory signaling and endothelial dysfunction. These diverse effects reflect a broader involvement of NAMPT in regulating bioenergetics, cell survival pathways, and inflammation under stress conditions."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "22", "end_ref": "31"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nRecent reviews and additional studies have further highlighted the multifaceted nature of NAMPT. Structural analyses have provided insights into its catalytic mechanism and substrate specificity, while clinical investigations link its expression to disease severity in conditions ranging from astrocytomas and metabolic syndrome to osteoarthritis. As both a functional enzyme regulating intracellular NAD⁺ levels and an extracellular signaling molecule, NAMPT emerges as a metabokine that can modulate cellular metabolism, inflammation, and tissue regeneration—thereby representing a promising target for therapeutic intervention and a potential biomarker for diverse pathologies."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "32"}, {"type": "fg_f", "ref": "6"}, {"type": "fg_fs", "start_ref": "33", "end_ref": "39"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Hongying Yang, Tianle Yang, Joseph A Baur, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cell.2007.07.035"}], "href": "https://doi.org/10.1016/j.cell.2007.07.035"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17889652"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17889652"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Antje Garten, Susanne Schuster, Melanie Penke, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Physiological and pathophysiological roles of NAMPT and NAD metabolism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Rev Endocrinol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nrendo.2015.117"}], "href": "https://doi.org/10.1038/nrendo.2015.117"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26215259"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26215259"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Eric van der Veer, Cynthia Ho, Caroline O'Neil, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Extension of human cell lifespan by nicotinamide phosphoribosyltransferase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.C700018200"}], "href": "https://doi.org/10.1074/jbc.C700018200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17307730"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17307730"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Mitsukuni Yoshida, Akiko Satoh, Jonathan B Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Extracellular Vesicle-Contained eNAMPT Delays Aging and Extends Lifespan in Mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Metab (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cmet.2019.05.015"}], "href": "https://doi.org/10.1016/j.cmet.2019.05.015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31204283"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31204283"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Sheila R Costford, Sudip Bajpeyi, Magdalena Pasarica, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Skeletal muscle NAMPT is induced by exercise in humans."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Endocrinol Metab (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpendo.00318.2009"}], "href": "https://doi.org/10.1152/ajpendo.00318.2009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19887595"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19887595"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Emmanuel S Burgos, Vern L Schramm "}, {"type": "b", "children": [{"type": "t", "text": "Weak coupling of ATP hydrolysis to the chemical equilibrium of human nicotinamide phosphoribosyltransferase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochemistry (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/bi801198m"}], "href": "https://doi.org/10.1021/bi801198m"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18823127"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18823127"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Alexander R Moschen, Arthur Kaser, Barbara Enrich, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Visfatin, an adipocytokine with proinflammatory and immunomodulating properties."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.178.3.1748"}], "href": "https://doi.org/10.4049/jimmunol.178.3.1748"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17237424"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17237424"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Janin Berndt, Nora Klöting, Susan Kralisch, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Plasma visfatin concentrations and fat depot-specific mRNA expression in humans."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2337/diabetes.54.10.2911"}], "href": "https://doi.org/10.2337/diabetes.54.10.2911"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16186392"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16186392"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "C A Curat, V Wegner, C Sengenès, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetologia (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00125-006-0173-z"}], "href": "https://doi.org/10.1007/s00125-006-0173-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16496121"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16496121"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Miao-Pei Chen, Fu-Mei Chung, Dao-Ming Chang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2005-1475"}], "href": "https://doi.org/10.1210/jc.2005-1475"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16234302"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16234302"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Song Hui Jia, Yue Li, Jean Parodo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI19930"}], "href": "https://doi.org/10.1172/JCI19930"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15124023"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15124023"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Claudio Pagano, Catia Pilon, Massimiliano Olivieri, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2006-0361"}], "href": "https://doi.org/10.1210/jc.2006-0361"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16720654"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16720654"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Tracy Luk, Zeenat Malam, John C Marshall "}, {"type": "b", "children": [{"type": "t", "text": "Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Leukoc Biol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1189/jlb.0807581"}], "href": "https://doi.org/10.1189/jlb.0807581"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18252866"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18252866"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Javed A Khan, Xiao Tao, Liang Tong "}, {"type": "b", "children": [{"type": "t", "text": "Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Struct Mol Biol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nsmb1105"}], "href": "https://doi.org/10.1038/nsmb1105"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16783377"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16783377"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "D G Haider, G Schaller, S Kapiotis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The release of the adipocytokine visfatin is regulated by glucose and insulin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetologia (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00125-006-0303-7"}], "href": "https://doi.org/10.1007/s00125-006-0303-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16736128"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16736128"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "L Li, G Yang, Q Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Clin Endocrinol Diabetes (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1055/s-2006-948309"}], "href": "https://doi.org/10.1055/s-2006-948309"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17177135"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17177135"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "B Wang, M K Hasan, E Alvarado, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2010.468"}], "href": "https://doi.org/10.1038/onc.2010.468"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20956937"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20956937"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "H Xie, S-Y Tang, X-H Luo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Insulin-like effects of visfatin on human osteoblasts."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Calcif Tissue Int (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00223-006-0155-7"}], "href": "https://doi.org/10.1007/s00223-006-0155-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17340225"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17340225"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Vijayalakshmi Varma, Aiwei Yao-Borengasser, Neda Rasouli, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2006-1303"}], "href": "https://doi.org/10.1210/jc.2006-1303"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17090638"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17090638"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Eric van der Veer, Zengxuan Nong, Caroline O'Neil, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pre-B-cell colony-enhancing factor regulates NAD+-dependent protein deacetylase activity and promotes vascular smooth muscle cell maturation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circ Res (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/01.RES.0000173298.38808.27"}], "href": "https://doi.org/10.1161/01.RES.0000173298.38808.27"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15947248"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15947248"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Abel López-Bermejo, Berta Chico-Julià, Mercè Fernàndez-Balsells, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Serum visfatin increases with progressive beta-cell deterioration."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2337/db06-0259"}], "href": "https://doi.org/10.2337/db06-0259"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17003355"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17003355"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Maria Pittelli, Laura Formentini, Giuseppe Faraco, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of nicotinamide phosphoribosyltransferase: cellular bioenergetics reveals a mitochondrial insensitive NAD pool."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M110.136739"}], "href": "https://doi.org/10.1074/jbc.M110.136739"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20724478"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20724478"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "D Friebe, M Neef, J Kratzsch, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetologia (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00125-010-2042-z"}], "href": "https://doi.org/10.1007/s00125-010-2042-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21298414"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21298414"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Santina Bruzzone, Floriana Fruscione, Sara Morando, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Catastrophic NAD+ depletion in activated T lymphocytes through Nampt inhibition reduces demyelination and disability in EAE."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0007897"}], "href": "https://doi.org/10.1371/journal.pone.0007897"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19936064"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19936064"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Sara M Camp, Ermelinda Ceco, Carrie L Evenoski, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Unique Toll-Like Receptor 4 Activation by NAMPT/PBEF Induces NFκB Signaling and Inflammatory Lung Injury."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep13135"}], "href": "https://doi.org/10.1038/srep13135"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26272519"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26272519"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Su-Ryun Kim, Soo-Kyung Bae, Kyu-Sil Choi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Visfatin promotes angiogenesis by activation of extracellular signal-regulated kinase 1/2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2007.03.105"}], "href": "https://doi.org/10.1016/j.bbrc.2007.03.105"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17408594"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17408594"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Ann Hammarstedt, Jussi Pihlajamäki, Victoria Rotter Sopasakis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Visfatin is an adipokine, but it is not regulated by thiazolidinediones."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2005-1395"}], "href": "https://doi.org/10.1210/jc.2005-1395"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16394088"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16394088"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Michele Cea, Antonia Cagnetta, Mariateresa Fulciniti, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Targeting NAD+ salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2012-03-416776"}], "href": "https://doi.org/10.1182/blood-2012-03-416776"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22955917"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22955917"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "A Garten, S Petzold, A Barnikol-Oettler, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2009.11.066"}], "href": "https://doi.org/10.1016/j.bbrc.2009.11.066"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19912992"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19912992"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Ernest Adeghate "}, {"type": "b", "children": [{"type": "t", "text": "Visfatin: structure, function and relation to diabetes mellitus and other dysfunctions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Curr Med Chem (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2174/092986708785133004"}], "href": "https://doi.org/10.2174/092986708785133004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18691043"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18691043"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "T Romacho, V Azcutia, M Vázquez-Bella, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetologia (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00125-009-1509-2"}], "href": "https://doi.org/10.1007/s00125-009-1509-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19727662"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19727662"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Dhanushika Ratnayake, Phong D Nguyen, Fernando J Rossello, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Macrophages provide a transient muscle stem cell niche via NAMPT secretion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41586-021-03199-7"}], "href": "https://doi.org/10.1038/s41586-021-03199-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33568815"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33568815"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Irina Kowalska, Marek Straczkowski, Agnieszka Nikolajuk, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Reprod (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/humrep/dem118"}], "href": "https://doi.org/10.1093/humrep/dem118"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17582143"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17582143"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Jacqueline M Stephens, Antonio J Vidal-Puig "}, {"type": "b", "children": [{"type": "t", "text": "An update on visfatin/pre-B cell colony-enhancing factor, an ubiquitously expressed, illusive cytokine that is regulated in obesity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Curr Opin Lipidol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/01.mol.0000217893.77746.4b"}], "href": "https://doi.org/10.1097/01.mol.0000217893.77746.4b"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16531748"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16531748"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Ming Zhong, Hong-wei Tan, Hui-ping Gong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Endocrinol (Oxf) (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1365-2265.2008.03248.x"}], "href": "https://doi.org/10.1111/j.1365-2265.2008.03248.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18363885"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18363885"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Ambra A Grolla, Cristina Travelli, Armando A Genazzani, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Pharmacol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/bph.13505"}], "href": "https://doi.org/10.1111/bph.13505"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27128025"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27128025"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "T D Filippatos, C S Derdemezis, D N Kiortsis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Endocrinol Invest (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/BF03346300"}], "href": "https://doi.org/10.1007/BF03346300"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17556870"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17556870"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Jonas Axelsson, Anna Witasp, Juan Jesús Carrero, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Kidney Dis (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1053/j.ajkd.2006.11.021"}], "href": "https://doi.org/10.1053/j.ajkd.2006.11.021"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17261426"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17261426"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "You Wu, Ying Zhang, Yu Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CircRNA hsa_circ_0005105 upregulates NAMPT expression and promotes chondrocyte extracellular matrix degradation by sponging miR-26a."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Biol Int (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cbin.10761"}], "href": "https://doi.org/10.1002/cbin.10761"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28276108"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28276108"}]}]}]}
|
| Synonyms | 1110035O14RIK, VF, PBEF1, VISFATIN, PBEF |
| Proteins | NAMPT_HUMAN |
| NCBI Gene ID | 10135 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
NAMPT has 22,465 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 126 datasets.
Click the + buttons to view associations for NAMPT from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by NAMPT gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of NAMPT gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NAMPT gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of NAMPT gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of NAMPT gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of NAMPT gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of NAMPT gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of NAMPT gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of NAMPT gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of NAMPT gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of NAMPT gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of NAMPT gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with NAMPT protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with NAMPT gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of NAMPT gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of NAMPT gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of NAMPT gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of NAMPT gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of NAMPT gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing NAMPT protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing NAMPT protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with NAMPT protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with NAMPT protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of NAMPT gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with NAMPT gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with NAMPT gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with NAMPT gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with NAMPT gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DGIdb Drug Targets 2026 | interacting drugs for NAMPT protein from the DGIdb Drug Targets 2026 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with NAMPT gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with NAMPT gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with NAMPT gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with NAMPT gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for NAMPT protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at NAMPT gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of NAMPT gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of NAMPT gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing NAMPT from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with NAMPT gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with NAMPT gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing NAMPT from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of NAMPT gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of NAMPT gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of NAMPT gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of NAMPT gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of NAMPT gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of NAMPT gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving NAMPT gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving NAMPT gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving NAMPT gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing NAMPT protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by NAMPT gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by NAMPT gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by NAMPT gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of NAMPT gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of NAMPT gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of NAMPT gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NAMPT gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with NAMPT gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with NAMPT gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with NAMPT gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for NAMPT protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of NAMPT gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of NAMPT gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of NAMPT protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NAMPT gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for NAMPT from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with NAMPT gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with NAMPT gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| HumanCyc Pathways | pathways involving NAMPT protein from the HumanCyc Pathways dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by NAMPT gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for NAMPT protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of NAMPT gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of NAMPT gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of NAMPT gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways 2026 | pathways involving NAMPT protein from the KEGG Pathways 2026 dataset. | |
| Kinase Library Serine Threonine Kinome Atlas | kinases that phosphorylate NAMPT protein from the Kinase Library Serine Threonine Atlas dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of NAMPT gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of NAMPT gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with NAMPT gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of NAMPT gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of NAMPT gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of NAMPT gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of NAMPT gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain NAMPT protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by NAMPT gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting NAMPT gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of NAMPT gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of NAMPT gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by NAMPT gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of NAMPT gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| MW Enzyme Metabolite Associations | interacting metabolites for NAMPT protein from the MW Gene Metabolite Associations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of NAMPT gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| NURSA Protein Complexes | protein complexs containing NAMPT protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for NAMPT from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of NAMPT gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of NAMPT gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving NAMPT protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving NAMPT protein from the Wikipathways PFOCR 2024 dataset. | |
| ProteomicsDB Cell Type and Tissue Protein Expression Profiles | cell types and tissues with high or low expression of NAMPT protein relative to other cell types and tissues from the ProteomicsDB Cell Type and Tissue Protein Expression Profiles dataset. | |
| Reactome Pathways 2014 | pathways involving NAMPT protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving NAMPT protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of NAMPT gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of NAMPT gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of NAMPT gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of NAMPT gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of NAMPT gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at NAMPT gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of NAMPT gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of NAMPT gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of NAMPT gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with NAMPT protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of NAMPT gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of NAMPT gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of NAMPT gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of NAMPT gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of NAMPT gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of NAMPT gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of NAMPT protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of NAMPT protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of NAMPT protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of NAMPT protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with NAMPT protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with NAMPT protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving NAMPT protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving NAMPT protein from the WikiPathways Pathways 2024 dataset. | |